Human Gut Microbiome Aging Clock Based on Taxonomic Profiling and Deep Learning.

Aging Aging Clock Applied Computing in Medical Science Artificial Intelligence Biogerontology Bioinformatics Deep Learning Microbiology Microbiome

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
26 Jun 2020
Historique:
received: 05 09 2019
revised: 14 04 2020
accepted: 21 05 2020
pubmed: 14 6 2020
medline: 14 6 2020
entrez: 14 6 2020
Statut: ppublish

Résumé

The human gut microbiome is a complex ecosystem that both affects and is affected by its host status. Previous metagenomic analyses of gut microflora revealed associations between specific microbes and host age. Nonetheless there was no reliable way to tell a host's age based on the gut community composition. Here we developed a method of predicting hosts' age based on microflora taxonomic profiles using a cross-study dataset and deep learning. Our best model has an architecture of a deep neural network that achieves the mean absolute error of 5.91 years when tested on external data. We further advance a procedure for inferring the role of particular microbes during human aging and defining them as potential aging biomarkers. The described intestinal clock represents a unique quantitative model of gut microflora aging and provides a starting point for building host aging and gut community succession into a single narrative.

Identifiants

pubmed: 32534441
pii: S2589-0042(20)30384-9
doi: 10.1016/j.isci.2020.101199
pmc: PMC7298543
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101199

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests F.G., P.M., and A.Z. are affiliated with Deep Longevity, Inc, a for-profit company developing biomarkers of aging and longevity commonly referred to as the “aging clocks. A.A., E.P., V.M., and A.Z. work for Insilico Medicine, a for-profit longevity biotechnology company developing the end-to-end target identification and drug discovery pipeline for a broad spectrum of age-related diseases. The microbiome aging model described in this article is a patent pending technology (application number 20200075127). The microbiomic aging clock is integrated in the Aging.AI system operated by the company. The company may have commercial interests in this publication.

Références

Microbiome. 2019 Aug 1;7(1):110
pubmed: 31370880
Appl Environ Microbiol. 1999 Nov;65(11):4799-807
pubmed: 10543789
Curr Biol. 2016 Jun 6;26(11):1480-5
pubmed: 27185560
Clin Diagn Lab Immunol. 2002 Jan;9(1):54-9
pubmed: 11777829
Mol Pharm. 2016 Jul 5;13(7):2524-30
pubmed: 27200455
Front Microbiol. 2014 Dec 10;5:678
pubmed: 25540641
Nature. 2013 Aug 29;500(7464):585-8
pubmed: 23985875
J Clin Biochem Nutr. 2018 Jul;63(1):33-35
pubmed: 30087541
Vaccine. 2013 Jun 10;31(26):2787-90
pubmed: 23602537
Front Microbiol. 2017 Nov 07;8:2166
pubmed: 29163445
Clin Microbiol Rev. 2007 Oct;20(4):593-621
pubmed: 17934076
BMC Genomics. 2016 Oct 21;17(1):819
pubmed: 27769168
PLoS One. 2010 May 17;5(5):e10667
pubmed: 20498852
Front Microbiol. 2016 Jun 28;7:979
pubmed: 27446020
Front Genet. 2018 Jul 12;9:242
pubmed: 30050560
Aging (Albany NY). 2018 Nov 9;10(11):3249-3259
pubmed: 30414596
Inflamm Bowel Dis. 2019 May 4;25(6):e71
pubmed: 30561647
Cell Mol Life Sci. 2019 Feb;76(3):473-493
pubmed: 30317530
BMC Microbiol. 2016 May 25;16:90
pubmed: 27220822
Nutr Healthy Aging. 2018 Jun 15;4(4):267-285
pubmed: 29951588
mSphere. 2017 Sep 27;2(5):
pubmed: 28959739
Nature. 2012 Sep 13;489(7415):220-30
pubmed: 22972295
Genomics Proteomics Bioinformatics. 2019 Feb;17(1):13-25
pubmed: 30986482
Front Microbiol. 2016 Aug 19;7:1204
pubmed: 27594848
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4578-85
pubmed: 20668239
Microbiome. 2013 Jan 09;1(1):2
pubmed: 24467949
Cell. 2015 Nov 19;163(5):1079-1094
pubmed: 26590418
Microb Biotechnol. 2019 Nov;12(6):1109-1125
pubmed: 31006995
Gut Pathog. 2013 Mar 18;5(1):5
pubmed: 23506618
J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1482-1490
pubmed: 29340580
Sci Rep. 2018 Mar 26;8(1):5210
pubmed: 29581467

Auteurs

Fedor Galkin (F)

Deep Longevity Inc, Hong Kong Science and Technology Park, Hong Kong; Integrative Genomics of Ageing Group, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.

Polina Mamoshina (P)

Deep Longevity Inc, Hong Kong Science and Technology Park, Hong Kong; Insilico Medicine Ltd, Hong Kong Science and Technology Park, Hong Kong.

Alex Aliper (A)

Insilico Medicine Ltd, Hong Kong Science and Technology Park, Hong Kong.

Evgeny Putin (E)

Insilico Medicine Ltd, Hong Kong Science and Technology Park, Hong Kong.

Vladimir Moskalev (V)

Insilico Medicine Ltd, Hong Kong Science and Technology Park, Hong Kong.

Vadim N Gladyshev (VN)

Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, USA.

Alex Zhavoronkov (A)

Deep Longevity Inc, Hong Kong Science and Technology Park, Hong Kong; Insilico Medicine Ltd, Hong Kong Science and Technology Park, Hong Kong; Buck Institute for Research on Aging, Novato, CA, USA; Biogerontology Research Foundation, London, UK. Electronic address: alex@insilico.com.

Classifications MeSH